196 related articles for article (PubMed ID: 6403565)
1. Gonadotropin-releasing hormone agonist suppresses ovulation, menses, and endometriosis in monkeys: an individualized, intermittent regimen.
Werlin LB; Hodgen GD
J Clin Endocrinol Metab; 1983 Apr; 56(4):844-8. PubMed ID: 6403565
[TBL] [Abstract][Full Text] [Related]
2. Ovulation inhibition by administration of weekly gonadotropin-releasing hormone antagonist.
Kenigsberg D; Hodgen GD
J Clin Endocrinol Metab; 1986 Apr; 62(4):734-8. PubMed ID: 3081571
[TBL] [Abstract][Full Text] [Related]
3. Treatment of endometriosis in monkeys: effectiveness of continuous infusion of a gonadotropin-releasing hormone agonist compared to treatment with a progestational steroid.
Mann DR; Collins DC; Smith MM; Kessler MJ; Gould KG
J Clin Endocrinol Metab; 1986 Dec; 63(6):1277-83. PubMed ID: 3097054
[TBL] [Abstract][Full Text] [Related]
4. Suppression of luteal function by a luteinizing hormone-releasing hormone antagonist during the early luteal phase in the stumptailed macaque monkey and the effects of subsequent administration of human chorionic gonadotropin.
Fraser HM; Nestor JJ; Vickery BH
Endocrinology; 1987 Aug; 121(2):612-8. PubMed ID: 3109885
[TBL] [Abstract][Full Text] [Related]
5. Titrating luteinizing hormone surge requirements for ovulatory changes in primate follicles. I. Oocyte maturation and corpus luteum function.
Zelinski-Wooten MB; Lanzendorf SE; Wolf DP; Chandrasekher YA; Stouffer RL
J Clin Endocrinol Metab; 1991 Sep; 73(3):577-83. PubMed ID: 1908481
[TBL] [Abstract][Full Text] [Related]
6. Follicular stimulation versus ovulation induction in juvenile primates: importance of gonadotropin-releasing hormone dose.
Sopelak VM; Collins RL; Hodgen GD
J Clin Endocrinol Metab; 1986 Mar; 62(3):557-62. PubMed ID: 3080466
[TBL] [Abstract][Full Text] [Related]
7. "Medical oophorectomy" using a long-acting GNRH agonist--a possible new approach to the treatment of endometriosis.
Meldrum DR; Chang RJ; Lu J; Vale W; Rivier J; Judd HL
J Clin Endocrinol Metab; 1982 May; 54(5):1081-3. PubMed ID: 6801075
[TBL] [Abstract][Full Text] [Related]
8. Antiovulatory actions of RU 486: the pituitary is not the primary site of action in vivo.
Heikinheimo O; Gordon K; Lähteenmäki P; Williams RF; Hodgen GD
J Clin Endocrinol Metab; 1995 Jun; 80(6):1859-68. PubMed ID: 7775633
[TBL] [Abstract][Full Text] [Related]
9. Recovery of hormone secretion after chronic gonadotropin-releasing hormone agonist administration in women with polycystic ovarian disease.
de Ziegler D; Steingold K; Cedars M; Lu JK; Meldrum DR; Judd HL; Chang RJ
J Clin Endocrinol Metab; 1989 Jun; 68(6):1111-7. PubMed ID: 2524501
[TBL] [Abstract][Full Text] [Related]
10. Titrating luteinizing hormone surge requirements for ovulatory changes in primate follicles. II. Progesterone receptor expression in luteinizing granulosa cells.
Chandrasekher YA; Brenner RM; Molskness TA; Yu Q; Stouffer RL
J Clin Endocrinol Metab; 1991 Sep; 73(3):584-9. PubMed ID: 1908482
[TBL] [Abstract][Full Text] [Related]
11. Chronic treatment with the gonadotropin-releasing hormone agonist D-Ser(TBU)6-EA10-LRH for contraception in women and men.
Nillius SJ; Bergquist C; Wide L
Int J Fertil; 1980; 25(3):239-46. PubMed ID: 6108935
[TBL] [Abstract][Full Text] [Related]
12. Even after priming with ovarian steroids or pulsatile gonadotropin-releasing hormone administration, naltrexone is unable to induce ovulation in women with functional hypothalamic amenorrhea.
Couzinet B; Young J; Brailly S; Chanson P; Schaison G
J Clin Endocrinol Metab; 1995 Jul; 80(7):2102-7. PubMed ID: 7608262
[TBL] [Abstract][Full Text] [Related]
13. Flexible protocol for administration of human follicle-stimulating hormone with gonadotropin-releasing hormone antagonist.
Byrd S; Itskovitz J; Chillik C; Hodgen GD
Fertil Steril; 1992 Jan; 57(1):209-14. PubMed ID: 1730319
[TBL] [Abstract][Full Text] [Related]
14. Treatment of endometriosis with a potent agonist of gonadotropin-releasing hormone (nafarelin).
Schriock E; Monroe SE; Henzl M; Jaffe RB
Fertil Steril; 1985 Nov; 44(5):583-8. PubMed ID: 2932349
[TBL] [Abstract][Full Text] [Related]
15. Impact of clomiphene citrate during ovarian stimulation on the luteal phase after GnRH agonist trigger.
Derksen L; Tournaye H; Stoop D; Van Vaerenbergh I; Bourgain C; Polyzos NP; Haentjens P; Blockeel C
Reprod Biomed Online; 2014 Mar; 28(3):359-68. PubMed ID: 24456700
[TBL] [Abstract][Full Text] [Related]
16. Gonadotropin-releasing hormone (GnRH) analog suppression renders polycystic ovarian disease patients more susceptible to ovulation induction with pulsatile GnRH.
Filicori M; Campaniello E; Michelacci L; Pareschi A; Ferrari P; Bolelli G; Flamigni C
J Clin Endocrinol Metab; 1988 Feb; 66(2):327-33. PubMed ID: 3123511
[TBL] [Abstract][Full Text] [Related]
17. Safety and efficacy of low dose hCG for luteal support after triggering ovulation with a GnRH agonist in cases of polyfollicular development.
Krause BT; Ohlinger R
Eur J Obstet Gynecol Reprod Biol; 2006 May; 126(1):87-92. PubMed ID: 16377065
[TBL] [Abstract][Full Text] [Related]
18. Human menopausal gonadotropin stimulation in monkeys: blockade of the luteinizing hormone surge by a highly transient ovarian factor.
Littman BA; Hodgen GD
Fertil Steril; 1984 Mar; 41(3):440-7. PubMed ID: 6421627
[TBL] [Abstract][Full Text] [Related]
19. Incorporation of a GnRH agonist, leuprolide acetate, into regimens with exogenous gonadotropins to produce ovarian stimulation and ovulation in the nonpregnant squirrel monkey.
Kuehl TJ; Davis TW; Young C; Nunez P; Robinson MR; Huddleston KP; Wincek TJ; Pliego JF; Dukelow WR
Am J Primatol; 1999 Oct; 49(2):153-64. PubMed ID: 10466574
[TBL] [Abstract][Full Text] [Related]
20. Intermittent GnRH antagonist plus progestin contraception conserving tonic ovarian estrogen secretion and reducing progestin exposure.
Danforth DR; Williams RF; Hsiu JG; Roh SI; Hahn D; McGuire JL; Hodgen GD
Contraception; 1990 Jun; 41(6):623-31. PubMed ID: 2113850
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
